A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved clinical outcomes in patients with HF across all quartiles of mitral ...

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with HF with moderate to severe or severe functional mitral regurgitation who underwent ...

January 6, 2012 (London, United Kingdom) — Results from the high-surgical-risk arm of the EVEREST II trial with the percutaneous MitraClip (Abbott) device, suggesting reduced mitral regurgitation and ...

CHICAGO -- Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation (MR) who didn't fit the COAPT profile, the EXPAND study showed. MR was often ...

MitraClip, a catheter-delivered device, has been approved by the US Food and Drug Administration (FDA) for treatment of patients with significant symptomatic degenerative mitral regurgitation who are ...

Surgical repair decreased MR more than MitraClip ®. In 12-month follow-up, 20% of MitraClip patients required surgery for mitral dysfunction versus 2% in surgical patients. Both groups had ...

Global health care major Abbott Laboratories ABT recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.

Technology in medicine changes so quickly. As doctors put those new techniques to use, some stand out as things that will soon become the norm. In this month’s MedWatch, we learn about a heart ...

The Ministry of Health Labour and Welfare ("MHLW") in Japan granted national reimbursement to Abbott 's ABT MitraClip therapy. The move is likely to improve the company's Structural Heart business.

Ducharme is a contributor to TIME. A MitraClip surgery at one of the University of Colorado Hospital's catheter labs on Thursday, July 17, 2014 in Aurora, CO. Ducharme is a contributor to TIME. A ...

Cardiomech AS raised $13 million in fresh capital via a convertible loan agreement that will go towards developing its transcatheter mitral valve chordal repair technology. The round was heavily ...